Pei Yang, Hamar Péter, Pei De-Sheng
School of Public Health, Chongqing Medical University, Chongqing 400016, China.
Chongqing No.11 Middle School, Chongqing 400061, China.
Toxics. 2025 Apr 12;13(4):303. doi: 10.3390/toxics13040303.
The rise of multidrug-resistant (MDR) () presents a significant challenge to clinical treatment and environmental risks. This review delves into the complex mechanisms underlying MDR development in , such as genetic mutations, horizontal gene transfer (HGT), and the interaction between virulence factors and resistance genes. It evaluates current detection methods, from traditional bacteriology to advanced molecular techniques, emphasizing the need for rapid and accurate diagnostics. This review also examines therapeutic strategies, including broad-spectrum antibiotics, novel drug candidates, combination therapies, and innovative approaches like RNA interference, CRISPR-Cas9 gene editing, and bridge RNA-guided gene editing. Importantly, this review highlights the distribution, migration, and environmental risks of MDR , underscoring its adaptability to diverse environments. It concludes by stressing the necessity for continued research and development in antimicrobial resistance, advocating for an integrated approach that combines genomics, clinical practice, and environmental considerations to devise innovative solutions and preserve antibiotic efficacy.
多重耐药(MDR)()的出现对临床治疗和环境风险构成了重大挑战。本综述深入探讨了MDR在(此处原文括号内容缺失,无法准确翻译该部分)中发展的复杂机制,如基因突变、水平基因转移(HGT)以及毒力因子与耐药基因之间的相互作用。它评估了从传统细菌学到先进分子技术的当前检测方法,强调了快速准确诊断的必要性。本综述还研究了治疗策略,包括广谱抗生素、新型候选药物、联合疗法以及RNA干扰、CRISPR - Cas9基因编辑和桥接RNA引导基因编辑等创新方法。重要的是,本综述强调了MDR(此处原文括号内容缺失,无法准确翻译该部分)的分布、迁移和环境风险,强调了其对不同环境的适应性。最后强调了在抗菌耐药性方面持续研发的必要性,倡导采用一种综合方法,将基因组学、临床实践和环境因素结合起来,以设计创新解决方案并保持抗生素疗效。